Cardiovascular diseases, respiratory diseases and cancer were assessed at baseline and for up to 180 days. The main biomarker studied was NNAL – 4-(methylnitrosamino)-1-(3-pyridyll)-1-butanol, showing the effects of nicotine-derived nitrosamine ketone (associated with lung cancer). In those who continue to smoke, its level remained stable throughout the observation period. In those who switched to the tobacco heating system, the level of NNAL decreased by 33-93%, in those who quit smoking – by 62-98% according to the analysis from the 30th […]

Read More

PET/CT is performed using different radiopharmaceuticals, depending on the organ under study:

PET/CT with glucose (18F-FDG) – for lung cancer, tumors of unknown localization, lymphomas, breast cancer, colorectal cancer, malignant melanoma of the skin, gynecological oncological diseases (ovarian cancer, cervical cancer), esophageal cancer, testicular cancer.

PAT/CT with methionine – for diseases of the brain.

PET / CT with choline (11C) – for diseases of the prostate gland, parathyroid adenoma.

What problem does PET/CT solve?

Diagnosis of neoplasms at the earliest stages.

Assessment of the prevalence of […]

Read More